Join the 'Systemic Lupus Erythematosus' group to help and get support from people like you.
Systemic Lupus Erythematosus News
Related terms: Disseminated Lupus Erythematosus, Lupus, SLE
Lupus, Type 1 Diabetes Linked to Pregnancy Complications
WEDNESDAY, March 20, 2024 – People with autoimmune disorders such as lupus, type 1 diabetes and rheumatoid arthritis tend to have fewer children, and women with this class of illnesses often have...
CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases
WEDNESDAY, Feb. 21, 2024 – CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published...
Obinutuzumab Preserves Kidney Function in Lupus Nephritis
THURSDAY, Nov. 16, 2023 – For patients with lupus nephritis (LN), obinutuzumab treatment results in better preservation of kidney function and prevention of LN flares, according to a study published...
COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia
TUESDAY, Oct. 10, 2023 – In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis,...
Ginger May Ease Inflammation of Autoimmune Diseases
MONDAY, Sept. 25, 2023 – Ginger supplements may help those with certain autoimmune diseases, such as lupus and rheumatoid arthritis, control inflammation. New research has added evidence to support...
Racial Discrimination Linked to Increased CRP in Black Women With Lupus
MONDAY, Aug. 14, 2023 – For Black women with systemic lupus erythematosus (SLE), incident racial discrimination is associated with elevated C-reactive protein (CRP), according to a study published...
Certain Microbiome Germs Might Trigger Lupus Flare-Ups
TUESDAY, June 27, 2023 – Flare-ups of the autoimmune condition lupus may be caused by growth of a particular gut bacteria, researchers say. This knowledge could potentially lead to new and more...
Pregnancy May Be Riskier for Women With Lupus
THURSDAY, April 27, 2023 – Pregnant women with lupus face potential complications, including a greater risk of premature birth, according to a new U.S. study. A 10-year audit of hospital records...
Fetal, Maternal Morbidity Increased for Patients With Lupus
WEDNESDAY, April 26, 2023 – Patients with systemic lupus erythematosus (SLE) have higher fetal and maternal morbidity in deliveries compared with those without SLE, according to a study published...
Skin Issues Can Be First Sign of Rheumatological Illnesses
TUESDAY, April 25, 2023 – Skin conditions may be the first sign that a person has a rheumatic disease that will also affect the joints, muscles or ligaments. It’s essential to know what to look for, ...
FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus
2 August 2021 – AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving ...
GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above
London UK, Philadelphia USA April 26, 2019 – GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of...
GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (belimumab) for Systemic Lupus Erythematosus
London, UK 21 July 2017 – GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients...
FDA Approves Benlysta to Treat Lupus
March 9, 2011 – The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, aspirin, triamcinolone, hydroxychloroquine, Plaquenil, cortisone, dexamethasone